Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Radius Health, Inc. (RDUS) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/05/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
11/08/2021 8-K Quarterly results
Docs: "Radius Health, Inc.: Third Quarter 2021 Results"
08/05/2021 8-K Quarterly results
Docs: "Radius Health, Inc.: Second Quarter and Year-to-Date Results"
05/07/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Radius Health, Inc.: Third Quarter 2020 Operating Results"
08/10/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
02/27/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
Docs: "Radius Health Announces Third Quarter 2019 Results and Corporate Update TYMLOS U.S. net sales grew to $47M and is capturing half of anabolic new patient starts 1"
08/07/2019 8-K Quarterly results
05/08/2019 8-K Quarterly results
Docs: "Radius Health Announces First Quarter 2019 Operating Results TYMLOS® U.S. net sales were $29.8 million in the first quarter of 2019 doubling over the first quarter of 2018."
02/28/2019 8-K Quarterly results
Docs: "Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results TYMLOS® U.S. net sales continued to increase, reaching $34.4 million in the fourth quarter of 2018 and totaling $99.2 million for full-year 2018, exceeding the Company’s guidance of $95-98 million."
11/01/2018 8-K Quarterly results
Docs: "Radius Health Announces Third Quarter 2018 Operating Results and Financial Guidance for FY 2018 and FY 2019 TYMLOS® U.S. net sales continued to increase in the third quarter of 2018, totaling $27.6 million. 2019 Medicare Part D coverage for TYMLOS increased from 44% to 64%"
08/07/2018 8-K Quarterly results
Docs: "Radius Health Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update Second quarter 2018 TYMLOS sales increase to $22.6 million, a 56% increase over the first quarter of 2018"
05/10/2018 8-K Quarterly results
Docs: "Radius Health Reports First Quarter 2018 Financial and Operating Results and Provides Business Update First quarter 2018 TYMLOS® sales increase to $14.5 million, a 90% increase over the fourth quarter of 2017"
03/01/2018 8-K Quarterly results
Docs: "Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update"
11/02/2017 8-K Quarterly results, Resignation/termination of a director
Docs: "First full quarter of TYMLOS™ sales shows accelerating market share & stabilization of the anabolic market Plan access at approximately 200 million lives – 87% commercial and 35% Medicare"
08/03/2017 8-K Quarterly results
05/01/2017 8-K Form 8-K - Current report
02/23/2017 8-K Form 8-K - Current report
11/03/2016 8-K Form 8-K - Current report
08/04/2016 8-K Form 8-K - Current report
05/05/2016 8-K Form 8-K - Current report
02/25/2016 8-K Quarterly results
Docs: "Radius Health Reports Fourth Quarter and Full Year 2015 Financial and Operating Results"
11/05/2015 8-K Quarterly results
Docs: "Radius Health Reports Third Quarter 2015 Financial and Operating Results"
08/06/2015 8-K Quarterly results
Docs: "Radius Health Reports Second Quarter 2015 Financial and Operating Results"
05/06/2015 8-K Quarterly results
Docs: "Radius Health Reports First Quarter 2015 Financial and Operating Results"
03/10/2015 8-K Quarterly results
Docs: "Radius Health Reports Fourth Quarter And Full Year 2014 Financial and Operating Results"
11/10/2014 8-K Quarterly results
Docs: "Recent Corporate Highlights"
08/12/2014 8-K Quarterly results
Docs: "Radius Health Reports Second Quarter 2014 Financial and Operating Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy